<p>Roy Kishony of Harvard University will seek to identify chemical entities that act as "selection inverters" which actively target antibiotic-resistant bacteria. Selection- inverters could be used in combination with traditional antibiotics to prevent resistance and possibly even drive a drug-resistant bacteria population back to drug sensitivity.</p>


Roy Kishony of Harvard University will seek to identify chemical entities that act as "selection inverters" which actively target antibiotic-resistant bacteria. Selection- inverters could be used in combination with traditional antibiotics to prevent resistance and possibly even drive a drug-resistant bacteria population back to drug sensitivity.